
Scott D. Locke
Partner
Chair, Intellectual Property Department
Education:
J.D., University of Pennsylvania School of Law, 1995
B.S. in Biology, Brown University, 1991,
magna cum laude
elected to Sigma Xi
Memberships:
U.S. District Court for the Southern District of New York
U.S. District Court for the Eastern District of New York
U.S. Court of Appeals for the Federal Circuit
U.S. Patent & Trademark Office
New York State
Connecticut
Scott D. Locke is the Chair of Dorf & Nelson’s Intellectual Property Department and oversees the Life Sciences practice area. Mr. Locke counsels clients on the procurement, enforcement and licensing of patents, trademarks, copyrights and trade secrets, and he provides solo inventors, start-up businesses and well-established companies in diverse industries with strategies and tools for maximizing the return on their investment in their ingenuity, creativity and goodwill.
Experience in Intellectual Property:
Mr. Locke has counseled clients in industries on the cutting edge of many scientific disciplines, including biotechnology, life sciences, bioinformatics, pharmaceuticals, fuel cells, automobile catalysts and eco-friendly technologies. He has also counseled clients in the coatings and pigments industry, the luxury goods industry, the cosmetics industry, the medical device industry, the consumer products industry, including both brick and mortar and e-commerce vendors, and the information technology industry. Among the services for these clients that Mr. Locke has provided are:
– Drafting, filing and prosecuting hundreds of patent applications
– Registering of trademark and copyright rights
– Litigating patent, trademark and copyright cases
– Performing due diligence regarding intellectual property assets for potential acquisition
– Drafting and negotiating intellectual property licenses
– Counseling clients on data privacy and database protection
– Developing trade secrets protection policies
Experience in Life Sciences:
Mr. Locke has provided legal services to innovative clients in the life sciences industry with respect to RNA synthesis; DNA synthesis; RNA interference, including siRNA and miRNA; SNP technologies; gene therapy; cosmetic formulations; detection of diseases and disorders; pharmaceuticals; and delivery systems. He has also counseled clients with respect to positioning and prosecuting patent portfolios, as well as litigating and licensing valuable intelligent property rights to these clients.